Features
The agent Irinotecan is a cytostatic and belongs to the therapeutic class of Topoisomerase I inhibitors.
ATC-Code: L01XX19
Our website uses cookies to enhance the user experience and provide the best possible service. By continuing to browse the website, you consent to our use of cookies. Click here to view the Privacy Policy.
Please click on the following links to download the documents:
The agent Irinotecan is a cytostatic and belongs to the therapeutic class of Topoisomerase I inhibitors.
ATC-Code: L01XX19
Strength is denoted by disposable cap color.
Irinotecan Kabi is indicated for the treatment of patients with advanced colorectal cancer:
Please note that this product may not be available in all countries due to different registration status.
Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.
If you require any information please contact your local organization.